Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01252940 |
|---|---|
| Brief Title: | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF |
| First Submitted : | December 1, 2010 |
| First Submitted that Met QC Criteria : | December 2, 2010 |
| First Posted : | December 3, 2010 (Estimate) |
| Results First Submitted : | March 8, 2013 |
| Results First Submitted that Met QC Criteria : | March 8, 2013 |
| Results First Posted : | April 19, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | October 27, 2015 |
| Last Update Posted : | December 4, 2015 (Estimate) |